Cargando…

Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?

Vaccination for Human Papillomavirus (HPV) is important to reduce rates of cervical and oropharyngeal cancer. We aimed to evaluate if a program to initiate HPV vaccination at 9 years improved initiation and completion rates by 13 years of age. Data on empaneled patients aged 9–13 years from January...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Leary, Sonja C., Frost, Holly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
HPV
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026893/
https://www.ncbi.nlm.nih.gov/pubmed/36892245
http://dx.doi.org/10.1080/21645515.2023.2180971
_version_ 1784909610479517696
author O’Leary, Sonja C.
Frost, Holly M.
author_facet O’Leary, Sonja C.
Frost, Holly M.
author_sort O’Leary, Sonja C.
collection PubMed
description Vaccination for Human Papillomavirus (HPV) is important to reduce rates of cervical and oropharyngeal cancer. We aimed to evaluate if a program to initiate HPV vaccination at 9 years improved initiation and completion rates by 13 years of age. Data on empaneled patients aged 9–13 years from January 1, 2021 to August 30, 2022 were abstracted from the electronic health record. Primary outcome measures included HPV vaccination initiation and series completion by 13 years of age. The secondary outcome measure was missed opportunities for HPV vaccination. In total, 25,888 patients were included (12,433 pre-intervention, and 13,455 post-intervention). The percentage of patients aged 9–13 with an in-person visit who received at least 1 dose of HPV vaccine increased from 30% pre-intervention to 43% post-intervention. The percentage of patients who received 2 doses of vaccine increased from 19.3% pre-intervention to 42.7% post-intervention. For the overall population seen in-person, initiation of HPV vaccination by age 13 years increased from 42% to 54%. HPV completion increased as well (13% to 18%). HPV vaccination initiation at 9 years of age may be an acceptable and effective approach to improving vaccination rates.
format Online
Article
Text
id pubmed-10026893
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-100268932023-03-21 Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13? O’Leary, Sonja C. Frost, Holly M. Hum Vaccin Immunother HPV Vaccination for Human Papillomavirus (HPV) is important to reduce rates of cervical and oropharyngeal cancer. We aimed to evaluate if a program to initiate HPV vaccination at 9 years improved initiation and completion rates by 13 years of age. Data on empaneled patients aged 9–13 years from January 1, 2021 to August 30, 2022 were abstracted from the electronic health record. Primary outcome measures included HPV vaccination initiation and series completion by 13 years of age. The secondary outcome measure was missed opportunities for HPV vaccination. In total, 25,888 patients were included (12,433 pre-intervention, and 13,455 post-intervention). The percentage of patients aged 9–13 with an in-person visit who received at least 1 dose of HPV vaccine increased from 30% pre-intervention to 43% post-intervention. The percentage of patients who received 2 doses of vaccine increased from 19.3% pre-intervention to 42.7% post-intervention. For the overall population seen in-person, initiation of HPV vaccination by age 13 years increased from 42% to 54%. HPV completion increased as well (13% to 18%). HPV vaccination initiation at 9 years of age may be an acceptable and effective approach to improving vaccination rates. Taylor & Francis 2023-03-09 /pmc/articles/PMC10026893/ /pubmed/36892245 http://dx.doi.org/10.1080/21645515.2023.2180971 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle HPV
O’Leary, Sonja C.
Frost, Holly M.
Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
title Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
title_full Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
title_fullStr Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
title_full_unstemmed Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
title_short Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
title_sort does hpv vaccination initiation at age 9, improve hpv initiation and vaccine series completion rates by age 13?
topic HPV
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026893/
https://www.ncbi.nlm.nih.gov/pubmed/36892245
http://dx.doi.org/10.1080/21645515.2023.2180971
work_keys_str_mv AT olearysonjac doeshpvvaccinationinitiationatage9improvehpvinitiationandvaccineseriescompletionratesbyage13
AT frosthollym doeshpvvaccinationinitiationatage9improvehpvinitiationandvaccineseriescompletionratesbyage13